Abdallah CG, Salas R, Jackowski A, Baldwin P, Sato JR, Mathew SJ (2015) Hippocampal volume and the rapid antidepressant effect of ketamine. J Psychopharmacol 29:591–595
CAS
Article
Google Scholar
Baer RA, Smith GT, Hopkins J, Krietemeyer J, Toney L (2006) Using self-report assessment methods to explore facets of mindfulness. Assessment 13:27–45
Article
Google Scholar
Barbosa PCR, Giglio JS, Dalgalarrondo P (2005) Altered states of consciousness and short-term psychological after-effects induced by the first time ritual use of ayahuasca in an urban context in Brazil. J Psychoactive Drugs 37:193–201
Article
Google Scholar
Beuningen J (2012) The satisfactin with life scale examining construct validity. Statistics Netherlands 201209:3–23
Bouso JC, González D, Fondevila S, Cutchet M, Fernández X, Barbosa PCR et al (2012) Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of ayahuasca: a longitudinal study. PLoS One 7:e42421
CAS
Article
Google Scholar
Catlow BJ, Song S, Paredes DA, Kirstein CL, Sanchez-Ramos J (2013) Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning. Exp Brain Res 228:481–491
CAS
Article
Google Scholar
Cebolla A, García-Palacios A, Soler J, Guillen V, Baños R, Botella C (2012) Psychometric properties of the Spanish validation of the five facets of mindfulness questionnaire (FFMQ). Eur J Psychiat 26:118–126
Article
Google Scholar
Da Silveira DX, Grob CS, de Rios MD, Lopez E, Alonso LK, Tacla C, Doering-Silveira E (2005) Ayahuasca in adolescence: a preliminary psychiatric assessment. J Psychoactive Drugs 37:129–133
Article
Google Scholar
Daza P, Novy DM, Stanley MA, Averill P (2002) The depression anxiety stress scale-21: Spanish translation and validation with a Hispanic sample. J Psychopathol Behav Assess 24:195–205
Article
Google Scholar
De Lima Osório F, De Macedo LRH, De Sousa JPM, Pinto JP, Quevedo J, de Souza Crippa JA, Hallak JEC (2011) The therapeutic potential of harmine and ayahuasca in depression: evidence from exploratory animal and human studies. The Ethnopharmacology of Ayahuasca: 75–86
Diener E, Emmons RA, Larsen RJ, Griffin S (1985) The satisfaction with life scale. J Pers Assess 49:71–75
CAS
Article
Google Scholar
Duman RS, Aghajanian GK (2012) Synaptic dysfunction in depression: potential therapeutic targets. Science 338:68–72
CAS
Article
Google Scholar
Farzin D, Mansouri N (2006) Antidepressant-like effect of harmane and other beta-carbolines in the mouse forced swim test. Eur Neuropsychopharmacol 16:324–328
CAS
Article
Google Scholar
Finberg JP, Rabey JM (2016) Inhibitors of MAO-A and MAO-B in psychiatry and neurology. Front Pharmacol 7:340
CAS
Article
Google Scholar
Forgeard MJ, Elstein JG (2014) Advancing the clinical science of creativity. Front Psychol 5:613
Article
Google Scholar
Fortunato JJ, Reus GZ, Kirsch TR, Stringari RB, Fries GR, Kapczinski F, Hallak JE, Zuardi AW, Crippa JA, Quevedo J (2010) Effects of beta-carboline harmine on behavioral and physiological parameters observed in the chronic mild stress model: further evidence of antidepressant properties. Brain Res Bull 81:491–496
CAS
Article
Google Scholar
Frecska E, Bokor P, Winkelman M (2016) The therapeutic potentials of ayahuasca: possible effects against various diseases of civilization. Front Pharmacol 7:35
Article
Google Scholar
Godinho AF, Silva MC, Kawashima JD, Horta DF, Anselmo F, De Fraia D (2017) Ayahuasca modifies amphetamine self ingestion and modifies anxiety and locomotor activity in adolescent rats. Electronic J Biol 13:159–165
Grob CS, McKenna DJ, Callaway JC, Brito GS, Neves ES, Oberlander G et al (1996) Human psychopharmacology of hoasca, a plant hallucinogen used in ritual context in Brazil. J Nerv Ment Dis 184:86–94
CAS
Article
Google Scholar
Halpern JH, Sherwood AR, Passie T, Blackwell KC, Ruttenber AJ (2008) Evidence of health and safety in American members of a religion who use a hallucinogenic sacrament. Med Sci Monit 14:15–22
Henry JD, Crawford JR (2005) The short-form version of the depression anxiety stress scales (DASS-21): construct validity and normative data in a large non-clinical sample. Br J Clin Psychol 44:227–239
Article
Google Scholar
Idell RD, Florova G, Komissarov AA, Shetty S, Girard RB, Idell S (2017) The fibrinolytic system: a new target for treatment of depression with psychedelics. Med Hypotheses 100:46–53
CAS
Article
Google Scholar
Kuypers KP, Riba J, de la Fuente RM, Barker S, Theunissen EL, Ramaekers JG (2016) Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking. Psychopharmacology 233:3395–3403
CAS
Article
Google Scholar
Lebudaa I, Zabelinab DL, Karwowskia M (2015) Mind full of ideas: a meta-analysis of the mindfulness–creativity link. Personal Individ Differ 93:22–26
Article
Google Scholar
Ma Z, Zang T, Birnbaum SG, Wang Z, Johnson JE, Zhang CL, Parada LF (2017) TrkB dependent adult hippocampal progenitor differentiation mediates sustained ketamine antidepressant response. Nature Communications 8:1668
McKenna DJ (2004) Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges. Pharmacol Ther 102:111–129
CAS
Article
Google Scholar
Morales-Garcia JA, Echeverry-Alzate V, Alonso-Gil S, Sanz-SanCristobal M, Lopez-Moreno JA, Gil C, Martinez A, Santos A, Perez-Castillo A (2017) Phosphodiesterase7 inhibition activates adult neurogenesis in hippocampus and subventricular zone in vitro and in vivo. Stem Cells 35:458–472
CAS
Article
Google Scholar
Nour MM, Evans L, Nutt D, Carhart-Harris RL (2016) Ego-dissolution and psychedelics: validation of the ego-dissolution inventory (EDI). Front Hum Neurosci 10:269
Article
Google Scholar
Osório FL, Sanches RF, Macedo LR, Santos RG, Maia-de-Oliveira JP, Wichert-Ana L, de Araujo DB, Riba J, Crippa JA, Hallak JE (2015) Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report. Rev Bras Psiquiatr 37:13–20
Article
Google Scholar
Palhano-Fontes F, Andrade KC, Tofoli LF, Santos AC, Crippa JA, Hallak JE, Ribeiro S, de Araujo DB (2015) The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network. PLoS One 10:e0118143
Article
Google Scholar
Re T, Palma J, Martins JE, Simões M (2016) Transcultual perspective on consciousness: traditional use of ayahuasca in psychiatry in the 21st century in the western world. Cosmos and History 12:237
Google Scholar
Riba J, Rodriguez-Fornells A, Urbano G, Morte A, Antonijoan R, Montero M, Callaway JC, Barbanoj MJ (2001) Subjective effects and tolerability of the south American psychoactive beverage Ayahuasca in healthy volunteers. Psychopharmacology 154:85–95
CAS
Article
Google Scholar
Roseman L, Nutt DJ, Carhart-Harris RL (2017) Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression. Front Pharmacol 8:974
Article
Google Scholar
Sampedro F, de la Fuente Revenga M, Valle M, Roberto N, Dominguez-Clave E, Elices M, Luna LE, Crippa JAS, Hallak JEC, de Araujo DB, Friedlander P, Barker SA, Alvarez E, Soler J, Pascual JC, Feilding A, Riba J (2017) Assessing the psychedelic “after-glow” in ayahuasca users: post-acute neurometabolic and functional connectivity changes are associated with enhanced mindfulness capacities. Int J Neuropsychopharmacol 20:698–711
Article
Google Scholar
Sanches RF, de Lima OF, Dos Santos RG, Macedo LR, Maia-de-Oliveira JP, Wichert-Ana L, de Araujo DB, Riba J, Crippa JA, Hallak JE (2016) Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a SPECT study. J Clin Psychopharmacol 36:77–81
CAS
Article
Google Scholar
Schmid JT (2012) The myth of ayahuasca. Int J Religion Spiritual Soc 3:257
Google Scholar
Soler J, Elices M, Franquesa A, Barker S, Friedlander P, Feilding A, Pascual JC, Riba J (2016) Exploring the therapeutic potential of Ayahuasca: acute intake increases mindfulness-related capacities. Psychopharmacology 233:823–829
CAS
Article
Google Scholar
Trichter S (2010) Ayahuasca beyond the Amazon the benefits and risks of a spreading tradition. J Transpers Psychol 42:131–148
Trichter S, Klimo J, Krippner S (2009) Changes in spirituality among ayahuasca ceremony novice participants. J Psychoactive Drugs 41:121–134
Article
Google Scholar
Vazquez C, Duque A, Hervas G (2013) Satisfaction with life scale in a representative sample of Spanish adults: validation and normative data. Span J Psychol 16:E82
Article
Google Scholar
Veehof MM, Peter M, Taal E, Westerhof GJ, Bohlmeijer ET (2011) Psychometric properties of the Dutch five facet mindfulness questionnaire (FFMQ) in patients with fibromyalgia. Clin Rheumatol 30:1045–1054
Article
Google Scholar
Viol A, Palhano-Fontes F, Onias H, de Araujo DB, Viswanathan GM (2017) Shannon entropy of brain functional complex networks under the influence of the psychedelic Ayahuasca. Sci Rep 7:73–88
Article
Google Scholar
Wardenaar KJ, Wanders RBK, Jeronimus BF et al (2018) The psychometric properties of an Internet-administered version of the depression anxiety and stress scales (DASS) in a sample of Dutch adults. J Psychopathol Behav Assess 40:318
Article
Google Scholar